Antibody Drug Conjugates Contract Manufacturing
Market
Antibody Drug Conjugates Contract Manufacturing
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
Antibody Drug Conjugates Contract Manufacturing
Market Size and Growth
The Antibody Drug Conjugates (ADCs) Contract Manufacturing market is poised for robust growth, driven by increasing demand for targeted therapies. The market size is projected to reach approximately $4 billion by 2027, fueled by advancements in ADC technologies and rising collaborations among biopharmaceutical companies for outsourcing manufacturing processes. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Lonza Group
◍ Merck KGaA
◍ Recipharm
◍ Thermo Fisher Scientific
◍ Abbvie
◍ Piramal Pharma Solutions
◍ Catalent
◍ Sterling Pharma Solutions
◍ Curia
◍ Novasep
◍ Ajinomoto Bio-Pharma Services
◍ BSP Pharmaceuticals
◍ Cerbios-Pharma
◍ Goodwin Biotechnology
The Antibody Drug Conjugates (ADC) Contract Manufacturing Market features key players like Lonza, Merck KGaA, and Thermo Fisher, offering expertise in ADC development and production. These companies enhance market growth by providing scalable manufacturing and innovative solutions. Sales revenue examples include:
- Lonza: Approximately $5 billion
- Thermo Fisher: Around $40 billion
- AbbVie: About $56 billion. Request Sample Report
Market Segmentation
By Application
Solid Tumors
Hematological Malignancies
By Product
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
